This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ao, M. Articles by Hayward, S. W. Search for Related Content PubMed PubMed Citation Articles by Ao, M. Articles by Hayward, S. W.

Cross-talk between Paracrine-Acting Cytokine and Chemokine Pathways Promotes Malignancy in Benign Human Prostatic Epithelium

Departments of ¹ Cancer Biology and ² Urologic Surgery, ³ Division of Hematology and Oncology, and ⁴ The Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee

Requests for reprints: Simon W. Hayward, Department of Urologic Surgery, A1302 MCN, Vanderbilt University Medical Center, Nashville, TN 37232-2765. Phone: 615-322-5823; Fax: 615-322-8990; E-mail: simon.hayward{at}vanderbilt.edu.

The present study explores the mechanisms by which human prostatic carcinoma-associated fibroblasts (CAF) induce tumorigenesis in initiated but nonmalignant human prostatic epithelial cells (BPH-1). CAF express elevated levels of both transforming growth factor-ß1 (TGF-ß1) and stromal cell–derived factor-1 (SDF-1/CXCL12). TGF-ß inhibits the growth of BPH-1 cells in vitro, but was found to be necessary for the tumorigenic response to CAF. This counterintuitive result suggested that the TGF-ß signaling system was involved in other processes relating to tumorigenesis. The SDF-1 receptor, CXCR4, is expressed at low levels in benign prostate tissue and in BPH-1 cells in culture. However, CXCR4 levels increase during prostate cancer progression. CXCR4 was found to be induced and localized to the cell membrane in BPH1 cells by CAF-conditioned medium and by CAF cells in tissue recombinants. TGF-ß was both necessary and sufficient to allow the detection of membrane-localized CXCR4 in BPH1 cells. Suppression of epithelial cell CXCR4 expression abrogated the tumorigenic response to CAF. SDF-1, secreted by CAF, acts via the TGF-ß–regulated CXCR4 to activate Akt in the epithelial cells. This mechanism elicits tumorigenesis and obviates the growth-inhibitory effects of TGF-ß. Thus, tumor stroma can contribute to carcinogenesis through synergism between TGF-ß, SDF-1, and CXCR4. These experiments suggest mechanisms by which TGF-ß can shift its role from an inhibitor to a promoter of proliferation during tumor progression. Both the TGF-ß and SDF-1 pathways are targets of drug discovery efforts; these data suggest potential benefits in the cotargeting of these pathways. [Cancer Res 2007;67(9):4244–53]

This article has been cited by other articles:

				S. Post, A. M. Smits, A. J. van den Broek, J. P.G. Sluijter, I. E. Hoefer, B. J. Janssen, R. J. Snijder, J. J. Mager, G. Pasterkamp, C. L. Mummery, et al. Impaired recruitment of HHT-1 mononuclear cells to the ischaemic heart is due to an altered CXCR4/CD26 balance Cardiovasc Res, October 8, 2009; (2009) cvp313v2. [Abstract] [Full Text] [PDF]

				D. Vindrieux, P. Escobar, and G. Lazennec Emerging roles of chemokines in prostate cancer Endocr. Relat. Cancer, September 1, 2009; 16(3): 663 - 673. [Abstract] [Full Text] [PDF]

				D. Basanta, D. W. Strand, R. B. Lukner, O. E. Franco, D. E. Cliffel, G. E. Ayala, S. W. Hayward, and A. R.A. Anderson The Role of Transforming Growth Factor-{beta}-Mediated Tumor-Stroma Interactions in Prostate Cancer Progression: An Integrative Approach Cancer Res., September 1, 2009; 69(17): 7111 - 7120. [Abstract] [Full Text] [PDF]

				V. L. Martins, J. J. Vyas, M. Chen, K. Purdie, C. A. Mein, A. P. South, A. Storey, J. A. McGrath, and E. A. O'Toole Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen J. Cell Sci., June 1, 2009; 122(11): 1788 - 1799. [Abstract] [Full Text] [PDF]

				Q. Zhang, B. T. Helfand, T. L. Jang, L. J. Zhu, L. Chen, X. J. Yang, J. Kozlowski, N. Smith, S. D. Kundu, G. Yang, et al. Nuclear Factor-{kappa}B-Mediated Transforming Growth Factor-{beta}-Induced Expression of Vimentin Is an Independent Predictor of Biochemical Recurrence after Radical Prostatectomy Clin. Cancer Res., May 15, 2009; 15(10): 3557 - 3567. [Abstract] [Full Text] [PDF]

				G. P. Risbridger and R. A. Taylor Regulation of Prostatic Stem Cells by Stromal Niche in Health and Disease Endocrinology, September 1, 2008; 149(9): 4303 - 4306. [Abstract] [Full Text] [PDF]

				N. J. Maitland and A. T. Collins Prostate Cancer Stem Cells: A New Target for Therapy J. Clin. Oncol., June 10, 2008; 26(17): 2862 - 2870. [Abstract] [Full Text] [PDF]

				M. Mimeault, P. P. Mehta, R. Hauke, and S. K. Batra Functions of Normal and Malignant Prostatic Stem/Progenitor Cells in Tissue Regeneration and Cancer Progression and Novel Targeting Therapies Endocr. Rev., April 1, 2008; 29(2): 234 - 252. [Abstract] [Full Text] [PDF]

				J. Wang, Y. Shiozawa, J. Wang, Y. Wang, Y. Jung, K. J. Pienta, R. Mehra, R. Loberg, and R. S. Taichman The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer J. Biol. Chem., February 15, 2008; 283(7): 4283 - 4294. [Abstract] [Full Text] [PDF]

				S. Yang, L. K. Pham, C.-P. Liao, B. Frenkel, A. H. Reddi, and P. Roy-Burman A Novel Bone Morphogenetic Protein Signaling in Heterotypic Cell Interactions in Prostate Cancer Cancer Res., January 1, 2008; 68(1): 198 - 205. [Abstract] [Full Text] [PDF]

				L. A. Begley, J. W. MacDonald, M. L. Day, and J. A. Macoska CXCL12 Activates a Robust Transcriptional Response in Human Prostate Epithelial Cells J. Biol. Chem., September 14, 2007; 282(37): 26767 - 26774. [Abstract] [Full Text] [PDF]

				Y. He, O. E. Franco, M. Jiang, K. Williams, H. D. Love, I. M. Coleman, P. S. Nelson, and S. W. Hayward Tissue-Specific Consequences of Cyclin D1 Overexpression in Prostate Cancer Progression Cancer Res., September 1, 2007; 67(17): 8188 - 8197. [Abstract] [Full Text] [PDF]